These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6804871)

  • 1. Activation of certain N-arylacetamides and N-arylacetohydroxamic acids in relation to mammary gland tumorigenesis in the rat.
    Malejka-Giganti D
    Natl Cancer Inst Monogr; 1981 Dec; (58):69-77. PubMed ID: 6804871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates.
    Malejka-Giganti D; Rydell RE; Gutmann HR
    Cancer Res; 1977 Jan; 37(1):111-7. PubMed ID: 830400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathobiologic and metabolic aspects of mammary gland tumorigenesis by N-substituted aryl compounds.
    Malejka-Giganti D; Ritter CL; Ryzewski CN
    Environ Health Perspect; 1983 Mar; 49():175-83. PubMed ID: 6339224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat mammary gland carcinogenesis after local injection of N-hydroxy-N-acyl-2-aminofluorenes: relationship to metabolic activation.
    Allaben WT; Weeks CE; Weis CC; Burger GT; King CM
    Carcinogenesis; 1982; 3(3):233-40. PubMed ID: 7083466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxidative metabolism of a carcinogen, N-hydroxy-N-2-fluorenylacetamide, by rat uterus and mammary gland in vitro.
    Malejka-Giganti D; Ritter CL; Decker RW; Suilman JM
    Cancer Res; 1986 Dec; 46(12 Pt 1):6200-6. PubMed ID: 3779640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of disulfiram on rat mammary tumor induction by N-2-fluorenylacetamide and on its metabolic conversion to N-hydroxy-N-2-fluorenylacetamide.
    Malejka-Giganti D; McIver RC; Rydell RE
    J Natl Cancer Inst; 1980 Jun; 64(6):1471-7. PubMed ID: 6929383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of metabolic activation of N-hydroxy-N-acylarylamines to biological response in the liver and mammary gland of the female CD rat.
    Shirai T; Fysh JM; Lee MS; Vaught JB; King CM
    Cancer Res; 1981 Nov; 41(11 Pt 1):4346-53. PubMed ID: 6118207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic basis for inhibitory effects in chemical carcinogenesis by arylamines.
    Grantham PH
    Natl Cancer Inst Monogr; 1981 Dec; (58):79-84. PubMed ID: 7341986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.
    Yost Y; Gutmann HR; Rydell RE
    Cancer Res; 1975 Feb; 35(2):447-59. PubMed ID: 1109807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring- and N-hydroxylations of N-2-fluorenylacetamide.
    Malejka-Giganti D; Decker RW; Ritter CL; Polovina MR
    Carcinogenesis; 1985 Jan; 6(1):95-103. PubMed ID: 3967341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsomal metabolism of the carcinogen, N-2-fluorenyl-acetamide, by the mammary gland and liver of female rats. II. Glucuronidation of ring- and N-hydroxylated metabolites of N-2-fluorenylacetamide.
    Malejka-Giganti D; Ryzewski CN
    Carcinogenesis; 1985 May; 6(5):687-92. PubMed ID: 3924428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free radicals in arylamine carcinogenesis.
    Floyd RA
    Natl Cancer Inst Monogr; 1981 Dec; (58):123-31. PubMed ID: 6281648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
    Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J
    Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of N-2-fluorenylacetamide-induced mammary tumorigenesis in rats by dietary polybrominated biphenyls.
    Schwartz EL; Kluwe WM; Sleight SD; Hook JB; Goodman JI
    J Natl Cancer Inst; 1980 Jan; 64(1):63-7. PubMed ID: 6243377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenic activation of N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide in subcellular fractions from X/Gf mice.
    Reddy TV; Weisburger EK; Thorgeirsson SS
    J Natl Cancer Inst; 1980 Jun; 64(6):1563-9. PubMed ID: 6929392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute or chronic treatment of rats with N-2-fluorenylacetamide on its N-hydroxylation and on hemoproteins of hepatic microsomes.
    Malejka-Giganti D; Ritter CL
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):53-64. PubMed ID: 7394317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells.
    Glowinski IB; Sanderson ND; Hayashi S; Thorgeirsson SS
    Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species difference in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide.
    Kaneda S; Seno T; Takeishi K
    J Natl Cancer Inst; 1981 Sep; 67(3):549-55. PubMed ID: 6944527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite profile in milk of lactating rats after treatment with a carcinogen, N-2-fluorenylacetamide.
    Malejka-Giganti D; Magat WJ; Adelmann AM; Decker RW
    Drug Metab Dispos; 1987; 15(6):760-6. PubMed ID: 2893699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.